Kangjian Miaomiao Secures RMB 100 Million Series A Funding to Accelerate DaaS System Development

VCBeat has learned that Health-Miumiu, a well-known domestic oral health data service platform, recently completed its RMB 100 million Series A financing round, co-led by KIP China and its existing shareholder, Jacobson Pharma.

This round of financing will be primarily used to develop digital solutions for dentistry; build a dental data platform based on AI technology, big data, and cloud services; and actively expand the business scale of its dental e-commerce platform, “Mei Miaomiao,” further solidifying its leading position in the dental e-commerce industry.

Image provided by Health-Miumiu

VCBeat has learned that, at present, by independently building a complete set of business and management systems,Health-MiumiuLeveraging e-commerce data as a channel, integrated with digital dentistry solutions and dental data services,It has cumulatively provided online procurement of dental instruments, consumables, pharmaceuticals, equipment, and other value-added services to over 50,000 dental clinics in China.

Meanwhile, to enhance logistics distribution efficiency and improve the user experience for dentists, Health-Miumiu has established six major logistics centers across China.

Furthermore, Health-Miumiu boasts an R&D team of nearly 100 members and three digital laboratories. While accumulating technological expertise, data resources, and user traffic, the company has vigorously developed oral health data chain products, successfully launching relevant systems and solutions that efficiently empower the dental industry.

Since its launch in August 2017, after four years of development, Meimiaomiao has gradually grown from scratch into a well-known domestic oral health e-commerce platform,In the future of dental big data and digitalization, Health-Miumiu will not limit itself to e-commerce platforms. Instead, it will expand in sync with dentists’ needs into multiple modules centered on DaaS (Data-as-a-Service) systems, including R&D and manufacturing of digital products, data services, medical services, e-commerce services, and value-added services.

VCBeat has learned that,Earlier, Health-Miumiu also reached a strategic cooperation with the South Korean listed company DIO.

Under the cooperation agreement, DIO will provide high-quality implant products and technical solutions to over 50,000 dental clinics currently served by Health-Miumiu, while collaborating with them to establish a robust and stable supply chain. Health-Miumiu has also become the exclusive distributor of the DIO RITH Implant System in China. The launch of DIO RITH dental implants on its platform marks the initiation of Health-Miumiu’s integrated online-to-offline (O2O) services.

Hu Jingzhi, Partner at KIP Capital Management, believes:“With the rapid development of China’s dental industry,"Health-Miumiu has effectively connected upstream suppliers with downstream clinics, covering nearly half of the clinics across China. It has established a clear market position, particularly with its big data and DaaS systems behind the platform, which offer significant growth potential. We look forward to the company’s future performance."

Dr. Kim Ji-soo, Director at KIP Capital“It is stated that: ‘Currently, the global oral care market is valued at approximately $265 billion, with China accounting for only about 6% of this market. As the national economy continues to grow rapidly, residents’ awareness of oral health is gradually increasing, indicating that this market undoubtedly has immense potential for development.’”“KIP is optimistic about the potential of the oral care market and has invested in multiple oral health-related projects in South Korea, including world-class enterprises. We will also introduce more high-quality dental resources to support the international development of Health-Miumiu.”

Mr. Yan Zhenliang, Executive Director of WatsonsIt believes: “China’s oral health market is vast and growing rapidly, and the application of digitalization and AI technologies has become an inevitable trend in the industry.”“We believe this financing will unlock the potential of Health-Miumiu’s digital dental product offerings and data platform development, while its active expansion of the scale of its dental e-commerce platform, ‘Mei Miaomiao,’ will create and deepen value-added opportunities.”

“Leveraging oral care e-commerce as an entry point, Health-Miumiu will launch an oral health data platform, gradually transitioning from serving clinics (To B) to serving dentists (To D),” said Lin Xiaoping, founder of Health-Miumiu. In the future, Health-Miumiu will continue to research, develop, and produce digital oral health products, oral health data software, and medical service platforms, aiming to become a trusted partner for dentists worldwide.

KIP is a leading venture capital firm in Asia. Since its establishment in 1986, it has maintained a steady investment pace and gradually grown into a venture capital institution based in Asia with investment reach extending to multiple regions worldwide. KIP focuses on the development of various emerging sectors, particularly biopharmaceuticals/big health, mass consumption/Internet of Things (IoT), and advanced technologies/AI. Its portfolio companies are distributed across Asia, Europe, and the Americas, with over 1,000 investments made to date. Among these, more than 300 companies have been listed on secondary markets in various countries and regions, and the cumulative assets under management exceed USD 5 billion.

Jacobson Pharma Corporation Limited is a leading generic pharmaceutical company in Hong Kong, China. Leveraging its vertically integrated supply chain and efficient production facilities, along with a balanced and diversified product portfolio, the Group has achieved extensive market coverage in both the private and public sectors in Hong Kong, China. It also has subsidiaries in mainland China, Singapore, Cambodia, and other regions.